Effect of Selective Serotonin Reuptake Inhibitors and Immunomodulator on Cytokines Levels: An Alternative Therapy for Patients with Major Depressive Disorder
| dc.contributor.affiliation | Department of Psychoimmunology, National Institute of Psychiatry “Ramon de la Fuente”, Calzada México-Xochimilco 101, Col. San Lorenzo Huipulco, Tlalpan, 14370 Mexico City, DF, Mexico | es_ES |
| dc.contributor.email | lkuriaki@imp.edu.mx | es_ES |
| dc.creator | Hernandez, María Eugenia | |
| dc.creator | Mendieta, Danelia | |
| dc.creator | Pérez-Tapia, Mayra | |
| dc.creator | Bojalil, Rafael | |
| dc.creator | Estrada-Garcia, Iris | |
| dc.creator | Estrada-Parra, Sergio | |
| dc.creator | Pavón, Lenin | |
| dc.creator.identificador | HEGE630202MDFRTG02>Hernandez, María Eugenia | es_ES |
| dc.creator.identificador | http://orcid.org/0000-0002-6067-6868>Pavon, Lenin | es_ES |
| dc.date.accessioned | 2017-06-29T03:46:39Z | |
| dc.date.accessioned | 2026-03-27T14:32:46Z | |
| dc.date.available | 2017-06-29T03:46:39Z | |
| dc.date.issued | 2013 | es_ES |
| dc.date.published | 2013 | es_ES |
| dc.description.abstractotrodioma | Major depressive disorder (MDD) is a psychiatric illness that presents as a deficit of serotonergic neurotransmission in the central nervous system. MDD patients also experience alterations in cortisol and cytokines levels. Treatment with selective serotonin reuptake inhibitors (SSRIs) is the first-line antidepressant regimen for MDD. The aim of this study was to determine the effect of a combination of SSRIs and an immunomodulator—human dialyzable leukocyte extract (hDLE)—on cortisol and cytokines levels. Patients received SSRIs or SSRIs plus hDLE. The proinflammatory cytokines IL-1β, IL-2, and IFN-γ; anti-inflammatory cytokines IL-13 and IL-10; and 24-h urine cortisol were measured at weeks (W) 0, 5, 20, 36, and 52 of treatment. The reduction in cortisol levels in the SSRI-treated group was 30% until W52, in contrast, the combined treatment induced a 54% decrease at W36. The decline in cortisol in patients who were treated with SSRI plus hDLE correlated with reduction of anti-inflammatory cytokines and increases levels of proinflammatory cytokines at the study conclusion. These results suggest that the immune-stimulating activity of hDLE, in combination with SSRIs, restored the pro- and anti-inflammatory cytokine balance and cortisol levels in depressed patients versus those who were given SSRIs alone. | es_ES |
| dc.identifier | 2664 | es_ES |
| dc.identifier.citation | Mercedes Simoni Nieves | es_ES |
| dc.identifier.doi | 10.1155/2013/267871 | es_ES |
| dc.identifier.eissn | 1740-2530 | es_ES |
| dc.identifier.issn | 1740-2522 | es_ES |
| dc.identifier.organizacion | Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz | es_ES |
| dc.identifier.paginacion | 1-11 | es_ES |
| dc.identifier.place | Egipto | es_ES |
| dc.identifier.uri | https://doi.org/10.1155/2013/267871 | es_ES |
| dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855951/ | es_ES |
| dc.identifier.uri | https://repositorio.inprf.gob.mx/handle/123456789/4513 | |
| dc.identifier.volumen | 2013 | es_ES |
| dc.language.iso | eng | es_ES |
| dc.relation | 2013 1-11p. | es_ES |
| dc.relation | versión del editor | es_ES |
| dc.relation.jnabreviado | CLIN DEV IMMUNOL | es_ES |
| dc.relation.journal | Clinical and Development Immunology | es_ES |
| dc.rights | acceso cerrado | es_ES |
| dc.subject.mesh | Adult | es_ES |
| dc.subject.mesh | Cytokines/blood | es_ES |
| dc.subject.mesh | Cytokines/metabolism | es_ES |
| dc.subject.mesh | Depressive Disorder, Major/drug therapy | es_ES |
| dc.subject.mesh | Depressive Disorder, Major/metabolism | es_ES |
| dc.subject.mesh | Female | es_ES |
| dc.subject.mesh | Humans | es_ES |
| dc.subject.mesh | Hydrocortisone/metabolism | es_ES |
| dc.subject.mesh | Hydrocortisone/urine | es_ES |
| dc.subject.mesh | Immunologic Factors/administration and dosage | es_ES |
| dc.subject.mesh | Immunologic Factors/therapeutic use | es_ES |
| dc.subject.mesh | Inflammation Mediators/blood | es_ES |
| dc.subject.mesh | Inflammation Mediators/metabolism | es_ES |
| dc.subject.mesh | Male | es_ES |
| dc.subject.mesh | Serotonin Uptake Inhibitors/administration and dosage | es_ES |
| dc.subject.mesh | Serotonin Uptake Inhibitors/therapeutic use | es_ES |
| dc.subject.mesh | Treatment Outcome | es_ES |
| dc.title | Effect of Selective Serotonin Reuptake Inhibitors and Immunomodulator on Cytokines Levels: An Alternative Therapy for Patients with Major Depressive Disorder | es_ES |
| dc.type | artículo | es_ES |
